SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-16-147584
Filing Date
2016-09-29
Accepted
2016-09-29 17:04:40
Documents
1
Period of Report
2016-09-28
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K a16-19252_18k.htm 8-K 19913
  Complete submission text file 0001104659-16-147584.txt   20939
Mailing Address 2150 WOODWARD ST., SUITE 100 AUSTIN TX 78744
Business Address 3711 SOUTH MOPAC EXPRESSWAY, STE 100 AUSTIN TX 78746 512-901-0900
Mirna Therapeutics, Inc. (Filer) CIK: 0001527599 (see all company filings)

IRS No.: 261824804 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37566 | Film No.: 161910553
SIC: 2834 Pharmaceutical Preparations